| Year |
Citation |
Score |
| 2020 |
Bononi A, Goto K, Ak G, Yoshikawa Y, Emi M, Pastorino S, Carparelli L, Ferro A, Nasu M, Kim JH, Suarez JS, Xu R, Tanji M, Takinishi Y, Minaai M, et al. Heterozygous germline mutations increase susceptibility to asbestos and mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318203 DOI: 10.1073/pnas.2019652117 |
0.577 |
|
| 2018 |
Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, Takinishi Y, Yamamoto R, Minaai M, Hashimoto-Tamaoki T, Ohmuraya M, Goto K, Goparaju C, Sarin KY, Tanji M, et al. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018790352. PMID 30376426 DOI: 10.1200/Jco.2018.79.0352 |
0.647 |
|
| 2017 |
Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, Pellegrini L, Signorato V, Olivetto F, Pastorino S, Nasu M, Napolitano A, Gaudino G, Morris P, Sakamoto G, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. PMID 28614305 DOI: 10.1038/Nature22798 |
0.576 |
|
| 2017 |
Carbone M, Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Pass HI, Yang H. Abstract 2553: High-density array-CGH with targeted NGS unmask multiple non-contiguous minute deletions on chromosome 3p21 in mesothelioma Cancer Research. 77: 2553-2553. DOI: 10.1158/1538-7445.Am2017-2553 |
0.559 |
|
| 2016 |
Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Tanji M, Pagano I, Gaudino G, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27834213 DOI: 10.1073/Pnas.1612074113 |
0.598 |
|
| 2015 |
Carbone M, Flores EG, Emi M, Johnson TA, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Powers A, Minaai M, Baumann F, Bryant-Greenwood P, Lauk O, et al. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s. Plos Genetics. 11: e1005633. PMID 26683624 DOI: 10.1371/Journal.Pgen.1005633 |
0.655 |
|
| 2015 |
Klebe S, Driml J, Nasu M, Pastorino S, Zangiabadi A, Henderson D, Carbone M. BAP1 hereditary cancer predisposition syndrome: a case report and review of literature. Biomarker Research. 3: 14. PMID 26140217 DOI: 10.1186/S40364-015-0040-5 |
0.591 |
|
| 2015 |
Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 565-76. PMID 25658628 DOI: 10.1097/Jto.0000000000000471 |
0.6 |
|
| 2015 |
Flores E, Emi M, Johnson T, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Baumann F, Yang H, Carbone M. Abstract 4796: A founder mutation in the BAP1 gene among four caucasian families with high incidences of malignant peritoneal mesothelioma and uveal melanoma: a molecular and genealogical study in a 10-generation BAP1 cancer syndrome kindred Cancer Research. 75: 4796-4796. DOI: 10.1158/1538-7445.Am2015-4796 |
0.636 |
|
| 2015 |
Nasu M, Pastorino S, Luk H, Flores E, Baumann F, Powers A, Kanodia S, Gaudino G, Zhang Y, Gazdar A, Yang H, Pass HI, Emi M, Carbone M. Abstract 3944: High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma Cancer Research. 75: 3944-3944. DOI: 10.1158/1538-7445.Am2015-3944 |
0.53 |
|
| 2014 |
Nasu M, Napolitano A, Pastorino S, Tanji M, Flores E, Baumann F, Powers A, Gaudino G, Pass HI, Yang H, Carbone M. Abstract 446: BAP1 mutation in mesothelioma and “BAP1 Cancer Syndrome” Cancer Research. 74: 446-446. DOI: 10.1158/1538-7445.Am2014-446 |
0.641 |
|
| 2011 |
Nasu M, Carbone M, Gaudino G, Ly BH, Bertino P, Shimizu D, Morris P, Pass HI, Yang H. Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth. Genes & Cancer. 2: 576-84. PMID 21901170 DOI: 10.1177/1947601911412375 |
0.487 |
|
| 2011 |
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5. PMID 21874000 DOI: 10.1038/Ng.912 |
0.602 |
|
| 2010 |
Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/Pnas.1006542107 |
0.672 |
|
| 2009 |
Yang H, Nasu M, Strianese O, Rivera Z, Luecke L, Carbone M. The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20. PMID 19365925 |
0.682 |
|
| Show low-probability matches. |